Lessee, Operating Lease, Liability, to be Paid, Year Two in USD of Propanc Biopharma, Inc. from Q2 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Propanc Biopharma, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two history and change rate from Q2 2019 to Q3 2025.
  • Propanc Biopharma, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Two for the quarter ending 30 Sep 2025 was $24.1K.
Lessee, Operating Lease, Liability, to be Paid, Year Two, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Two, YoY Quarterly Change (%)

Propanc Biopharma, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $24.1K 30 Sep 2025 10-Q 14 Nov 2025
Q2 2025 $25K 30 Jun 2025 10-K 29 Sep 2025
Q2 2023 $20K -$4.9K -19.7% 30 Jun 2023 10-K 28 Sep 2023
Q1 2023 $20.1K 31 Mar 2023 10-Q 15 May 2023
Q4 2022 $20.4K 31 Dec 2022 10-Q 10 Feb 2023
Q3 2022 $23.2K 30 Sep 2022 10-Q 14 Nov 2022
Q2 2022 $24.9K 30 Jun 2022 10-K 28 Sep 2022
Q1 2020 $22.8K 31 Mar 2020 10-Q 15 May 2020
Q4 2019 $23.1K 31 Dec 2019 10-Q 14 Feb 2020
Q3 2019 $22.8K 30 Sep 2019 10-Q 14 Nov 2019
Q2 2019 $28.3K 30 Jun 2019 10-K 15 Oct 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.